PLYX PLYX
Company Profile ↓Company Overview
PLYX (PLYX) is a publicly traded company listed on with a market capitalization of $106.05M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -93.60% |
| 6 Months: | -89.79% |
| 3 Months: | -50.66% |
| 1 Month: | -11.46% |
- Price vs 50-DMABelow
- RSI (14)46.65 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 93.6% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | 5.05M | 884.00K | 974.00K | 911.00K | 1.96M |
| Operating Income | - | -5.05M | -884.00K | -974.00K | -911.00K | -1.96M |
| EBITDA | - | -5.05M | -884.00K | -974.00K | -911.00K | -1.96M |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | -5.05M | -1.01M | -1.43M | -1.50M | -2.54M |
| Tax Provision | - | - | - | - | - | - |
| Net Income | - | -5.05M | -1.01M | -1.43M | -1.50M | -2.54M |
| Diluted EPS | - | -0.11 | -0.02 | -0.03 | - | -0.05 |
| R&D Expense | - | 4.72M | - | - | - | 679.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | 3.78M | 4.35M | 7.82M |
| Operating Income | -3.78M | -4.35M | -7.82M |
| EBITDA | -3.78M | -4.35M | -7.82M |
| Interest Expense | - | - | - |
| Pretax Income | -3.78M | -30.36M | -8.98M |
| Tax Provision | - | - | - |
| Net Income | -3.78M | -30.36M | -8.98M |
| Diluted EPS | -0.08 | -0.64 | -0.19 |
| R&D Expense | - | 2.81M | 6.27M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Total Assets | 2.31M | 5.00M | 5.17M |
| Current Assets | 2.31M | 5.00M | 5.17M |
| Cash & Equivalents | 2.00K | 4.62M | 5.14M |
| Inventory | - | - | - |
| Receivables | - | - | - |
| Total Liabilities | 1.04M | 289.00K | 605.00K |
| Current Liabilities | 1.04M | 289.00K | 605.00K |
| Long Term Debt | - | - | - |
| Total Debt | 128.00K | - | - |
| Total Equity | 1.28M | 4.71M | 4.57M |
| Shares Outstanding | 47.34M | 47.34M | 47.34M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | -173.00K | -2.57M | -3.94M |
| Investing Cash Flow | - | - | - |
| Financing Cash Flow | 128.00K | 7.19M | 4.47M |
| Capital Expenditure | - | - | - |
| Free Cash Flow | -173.00K | -2.57M | -3.94M |
| Net Change in Cash | -45.00K | 4.62M | 522.00K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | - | - | - |
| Operating Margin % | - | - | - |
| Net Margin % | - | - | - |
| ROE % | -295.9% | -644.2% | -196.8% |
| ROCE % | -296.1% | -92.4% | -171.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PLYX
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9MWl83QmxVZllZei1OaVFyMWtVNUNBcDdid081TWVjdy1KVnkxaGpaTTBzcmI0Vm9yeUlDaW5veW5VTUYzTU1icHp5R3dEcjY2?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
$PLYX stock is down 32% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQcXJVV2Q1MlByMmJDNWlPS00yTVBzV1BDRkJVczBrcHZsOHdaLTVoSzJzSXFocXRTN1dpdUlQOWNLNGRhZ2dZQWJ5WXpFNXBLQW1nRkd0aFRmdlBuZTJscVNVMjhiNm96clY1aE9KQkRhNjZXeVoxNl9KdnlJSElKaUk0UnVQRHRYaUxiNj…
Polaryx Therapeutics, Inc. SEC Filing (Jul 28, 2026) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPbWllNkVYdjk0R0swRkZPY0d0UW5HUFM5SzY0UzFNd1preURsUkRIX0p4SFVaLXg0ZWN4TE44Tm9OUDFFRE9TZkFGUUtmOGlXaGxOeWtJQkVFcFNIRnM1a3pnclNSbV80RzNuTUl3XzYzQzFHeWxvX3NGNElLTW5NbmpVdldIa0I4MjNRU2…
Polaryx Therapeutics CEO’s Mstone buys $360,003 in PLYX stock - Investing.com
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOOFVDQXJWWk9IS3dHdXBOejhCblVjYTVXdFNyNzNDV2xpc2xWTEE0ZmdHMVh2Q0RsLXIwRnMzRGo3ZU1LY0tYSlRESTlaT1NVbWhHVnZEdXN4Wjg2N25pZWxFWE5pYk9IXzJaOW9IRE4zOWNPOWUxRzl5UUtHT1hVdkl6MnptSFRFM0lqMm…
PLYX Stock Price and Chart — NASDAQ:PLYX - TradingView
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5yb04xdnV1NWxCcUt5OFJ2Q1NwSnc0NFVIOFNxQW1oZU16a2FqQUxOU2ZtMkFtbGY2ajhLYmNSM0lRcDdGQm56eVV3RUhBbXF1X0pRcUNJSUdpcjVY?oc=5" target="_blank">PLYX Stock Price and Chart — NASDAQ:PLYX</a…
Polaryx Therapeutics (NASDAQ:PLYX) Downgraded by Wall Street Zen to "Sell" - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPVlJCUzB6MHdYRGF4eFpaTVdwX25NcHFJVmtMVHVVUzVhNTlKR1FDbW51b2NySnNyS1Y5UFBHOGxGZmFLOEFzSzZ6ZDZTakg3NUF5NW1uLVluWHNXalFRUG1tZVJQZzJVZFVxUnpsdlhEWjlZZWlmV19CWUgzLW12WUVDVGhFY1lJdUNwbV…
PLYX — Frequently Asked Questions
What is the current share price of PLYX?
As of 2026-08-05 17:25 PDT, PLYX trades at $2.24 on NASDAQ/NYSE. Its 52-week range is $1.96 to $35.00.
What is the market capitalisation of PLYX?
PLYX has a market capitalisation of $106.05M on NASDAQ/NYSE.
What is the P/E ratio of PLYX?
PLYX trades at a trailing price-to-earnings (P/E) ratio of -11.80. Its price-to-book (P/B) ratio is 23.24.
Is PLYX a good stock to buy?
This page provides a data-driven analysis of PLYX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.